MedMira

MedMira

Launching an OTC product in the US

MedMira is a company that has decided to launch an OTS HIV testing product in the United States' market. Launching an OTC product in the United States is not easy. The company has to make sure that it has done proper research and has found the proper advantages and disadvantages of launching a product in the over-the-counter market. With the increase in the HIV/AIDS cases, it was necessary that action is taken to overcome the problem so that the lives of the people are saved. The change in the general environment such as the change in the common perceptions of the people has helped the company in thinking to launch the product (hbr.org). The changes in the legal framework under which the test should be conducted also contributed to the introduction of the product in the Over-the-Counter market of the United States (Grant, 2009). Huge investments in the technology industry also helped the company in launching a product in the OTC market. This ensured that MedMira is confident and knows that the product that it will launch will prove to be beneficial for the people using it.

Ethical Issues

The first and foremost ethical concern was that the company was required to obtain an informed consent from the patient while conducting the HIV test. This was a requirement by law and the company had to make sure that this requirement was fulfilled so that no ethical concern can be raised. Another ethical issue was that the results of the HIV tests could be used inappropriate and inadequately and the results could be manipulated. This meant that the people who were involved in this did not completely trust OTC market and it was difficult for the company to make sure that the people start trusting ...